Urology Book

//fpnotebook.com/

Active Surveillance of Prostate Cancer

Aka: Active Surveillance of Prostate Cancer, Canadian Prostate Cancer Surveillance Protocol
  1. See Also
    1. Prostate Cancer
    2. Prostate Cancer Management
    3. Prostate Cancer Composite Risk
    4. Prostate Cancer Very Low Risk
  2. Background
    1. Canadian protocol for Prostate Cancer active surveillance
  3. Indications
    1. See Prostate Cancer Composite Risk for criteria
    2. Life Expectancy >15 years and
      1. See Charlson Comorbidity Index (Comorbidity-Adjusted Life Expectancy)
    3. Prostate Cancer Very Low Risk of progression
      1. PSA <10 ng/ml
      2. Gleason =6
      3. Stage T2a or less
      4. Prostate biopsy with <3 cores positive for cancer, less than 50% of cores involved, and PSA density <0.15
  4. Protocol: Surveillance
    1. PSA and Digital Rectal Exam
      1. Initial: Every 3 months for 2 years
      2. Later: Every 6 months
    2. Transrectal Ultrasound-guided biopsy with 10-12 core biopsies at one year and then every 3 years until age 80 years
    3. Consider transrectal Ultrasound on alternate exam dates
  5. Protocol: Intervention indications
    1. PSA doubling time <3 years based on =8 values
    2. Gleason Score progresses to =7
  6. References
    1. Klotz (2005) J Clin Oncol 23(32): 8165-9 [PubMed]

You are currently viewing the original 'fpnotebook.com\legacy' version of this website. Internet Explorer 8.0 and older will automatically be redirected to this legacy version.

If you are using a modern web browser, you may instead navigate to the newer desktop version of fpnotebook. Another, mobile version is also available which should function on both newer and older web browsers.

Please Contact Me as you run across problems with any of these versions on the website.

Navigation Tree